Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells
Colorectal cancer (CRC) is the third most leading cause of morbidity and mortality throughout the world. 5-fluorouracil (5-FU), which is often administrated to disrupt carcinogenesis, was found to elevate blood glucose level among CRC patients. Thus, this study was conducted to evaluate the influenc...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
Leibniz Research Centre for Working Environment and Human Factors
2018
|
| Subjects: |